![](/img/cover-not-exists.png)
Block sequential adriamycin CMF – optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer?
Cameron, D A, Anderson, A, Toy, E, Evans, T R J, Le Vay, J H, Kennedy, I C S, Grieve, R J, Perren, T J, Jones, A, Mansi, J, Crown, J, Leonard, R C FVolume:
87
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/sj.bjc.6600660
Date:
December, 2002
File:
PDF, 84 KB
english, 2002